Estée Lauder (EL)
The desk's stance
On our research list, not on the slate.
What the company does
The prestige house of houses — MAC, Clinique, La Mer, Tom Ford — mid-turnaround after China travel-retail collapsed and an entire generation discovered the dupes of its hero products.
In short: Prestige cosmetics and skincare manufacturer. Category: Prestige Beauty Turnaround. Sector: Consumer Defensive, Household & Personal Products.
G-Street Value and Score
G-Street Value: $82.66, computed Oct 18, 2026 (confidence: low).
How we got there: 50% analyst leg $101.22 (2 analyst targets, credibility- and freshness-weighted, after 8% optimism discount) + 50% GainStreet factor value $64.09 (16.31× fwd EPS anchored to consumer-defensive multiples) — analyst and factor views diverge >50%, confidence reduced. 2 analyst targets have no linked source and are shown but not counted.
G-Street Score: 51 out of 100 (Weak).
- Top-line growth & guidance: 7 of 32
- Margin power: 15 of 15
- Revenue visibility & quality: 4 of 11
- Profitability & balance sheet: 13 of 24
- Capital allocation & governance: 5 of 6
- Valuation, sentiment & momentum: 7 of 12
Our current thesis
Updated Oct 17, 2026
The thesis
- PRGP restructuring execution stabilizes gross margins at 75.5% while generating $1.32B free cash flow.
- Four consecutive quarterly beats indicate improving channel inventory discipline and price realization.
- Core prestige skincare and fragrance hero portfolios maintain pricing power and brand equity.
Risks
- Net margin of 1.2% severely trails peer L'Oréal's 14% at comparable forward valuation multiples.
- Elevated $9.25B debt load and 243% debt-to-equity limit capital return and operational flexibility.
- Prolonged China travel retail volatility and masstige dupe competition pressure prestige skincare volumes.
What we're watching
- Fiscal Q1 2027 earnings release scheduled for November 2, 2026.
- Sequential operating margin progression toward management's full-year 12.7% to 13.5% guidance range.
- Consolidation behavior around the $108 median analyst consensus target and technical resistance.
Latest
Estée Lauder trades at $104.54 (26.6x forward P/E) after a 34% six-month rally driven by four consecutive earnings beats and gross margin stabilization at 75.5%. Trailing free cash flow reached $1.32B, though reported net margin remains compressed at 1.2% due to ongoing restructuring charges and debt service on $9.25B of obligations. Street sentiment is converging near current price levels with Morgan Stanley lifting its target to $112 (Equal Weight) while Barclays raised to $108 (Overweight).
Key numbers
As of Oct 16, 2026: market cap $37.9B · revenue growth +6.3% year over year · gross margin 75.5% · net margin 1.2% · forward P/E 26.6 · next earnings Nov 2, 2026.
Analyst price targets
Published analyst targets we could trace to a named source.
- Morgan Stanley, Equal Weight: $112 target (October 2026). Source: marketbeat.com
- Barclays, Overweight: $108 target (October 2026). Source: seekingalpha.com
On the Gainz Lab maps
Who it does business with
- International Flavors & Fragrances supplies Estée Lauder — Fragrance & ingredients. The scent-and-actives layer under the whole industry — prestige houses lean hardest on the big ingredient labs.
- e.l.f. Beauty competes with Estée Lauder — The dupe economy. e.l.f.'s playbook is duplicating prestige hero products at a fifth of the price — Estée Lauder's brands are the originals being duped.
- Estée Lauder competes with LVMH (Sephora, Fenty, Dior Beauty) — Prestige counters. The department-store and travel-retail turf war: MAC and Clinique vs Dior Beauty and Fenty.
- Estée Lauder supplies The Beauty Consumer — The prestige receipt (about $15.0B a year). Prestige beauty sells identity and gifting — the counters, the compacts, the little brown box.